Axsome Therapeutics Inc

AXSM:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/22/21 EST
74.75quote price arrow up+0.10 (+0.13%)
Volume
9,049
Close
74.65quote price arrow down-1.25 (-1.65%)
Volume
234,360
52 week range
35.44 - 109.53

...

Loading . . .

KEY STATS

  • Open75.19
  • Day High75.99
  • Day Low74.56
  • Prev Close75.90
  • 52 Week High109.53
  • 52 Week High Date04/27/20
  • 52 Week Low35.44
  • 52 Week Low Date03/18/20
  • Market Cap2,787.43M
  • Shares Out37.34M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta2.53
  • 1 Year % Change-14.94

RATIOS/PROFITABILITY

  • EPS (TTM)-2.70
  • P/E (TTM)-27.66
  • Fwd P/E (NTM)-20.62
  • EBITDA (MRQ)-95.80M
  • ROE (MRQ)-138.71%
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)35.51%

EVENTS

  • Earnings Date03/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Axsome Therapeutics Inc News

There is no recent news for this security.

Latest AXSM News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02 (disodium zoledronate tetrahydrate), is an oral, targeted, non opioid therapeutic for chronic pain. It is developing AXS 02 for the treatment of pain...
Herriot Tabuteau M.D.
Chairman
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Address
22 CORTLANDT STREET, 16TH FLOOR
New York, NY
10007
United States